[ad_1]
Maria Spirova STAFF: BTV / Archive
Bulgarian Maria Spirova, one of the volunteers testing the COVID-19 vaccine in Britain, had a fever just two days after the first dose. This is what Spirova said on the BTV morning block.
The clinical trial of the vaccine continues in the UK, Brazil and other countries among different groups of people, he said. He explained that testing has yet to resume in the United States and there have been four advanced vaccines in the world. Britain has already doubled the second dose of vaccine, which was given to Spirova.
The vaccine protects me from being a distributor. Some vaccines keep you from having a bad time, but it doesn’t stop you from being a distributor, he explained. She said the most common effect of the vaccine was fever, as it happened to her, but that it disappeared within two days. After the second dose, she did not have a fever, she only felt tired for a short time. Doctors gave her literature to read and kept asking her if she wanted to continue testing. “They are trying to keep us informed,” he added. He also donated blood to the laboratory every ten days to monitor his condition, and had a PCR test every week.
I decided to participate because I was living in London when the virus hit us and the government decided to shut down Great Britain. It is a great shock to see London stand still. But I realize that we have to go on with our normal lives. No one, no matter what they believe about the virus, can get on with their life, and the only way to do that is to invent a vaccine for the most vulnerable, he said. He added that he was in a rush to invent the vaccine because the world could not wait and continue to suffer economic damage.
We were initially expected to be clinically healthy, but we were not expected to protect ourselves. We are testing whether an immune system will cope better with the virus than the one that received the vaccine, Spirova explained.
[ad_2]
